Peripheral vascular disease - both arterial and venous - can have devastating consequences for persons with chronic kidney disease (CKD). This session reviews assessment of arterial and venous vascular disease, nursing interventions, and evidence-based pharmacologic and non-pharmacologic treatment.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 11/8/2022.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure: Speaker: Kristin Larson – Employee, United Health Group, Astra Zeneca Speakers Bureau
There are no other disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome: Upon completion of this activity the nephrology nurse will be able to discuss the evidence available to plan and provide nursing care to a patient with PVD and PKD.